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Background: Non-communicable diseases are the leading causes of global burden of diseases, and hypertension is
one of the most important risk factors. Hypertension prevalence doubled in China in the past decade and affects
more than 300 million Chinese people. In the review we systematically searched peer-reviewed publications that
link health system level factors with hypertension management in China and provide the current knowledge on
how to improve a country’s health system to manage the hypertension epidemic.
Methods: A framework was developed to guide the review. The database of PubMed, CNKI were systematically searched
from inception to April 13, 2016. Two authors independently screened the searched results for inclusion, conducted data
extraction and appraised the quality of studies. Key findings were described according to the framework.
Findings: Five hundred seventy-two publications were identified, where 11 articles were left according to the inclusion
and exclusion criteria. The study periods range from 2010 to 2015. All about 11 researches linked health system factors to
the outcome of hypertension management. And the outcomes were just focused on the awareness, treatment and
control of hypertension but not hypertension incidence. One study is about the role of health system governance,
investigating the performance of different organized community health care centers; three studies were about health
financing comparing differences in insurance coverage; three studies were about health information practicing the
hypertension guidelines of China or the WHO, and the rest three about mechanisms of health service delivery. No
researches were identified about physical resources for health and human resources for health.
Conclusions: Hypertension prevalence has been rising rapidly in China and the management of hypertension in China is
a detection problem rather than treatment problem. Limited evidence shows the positive effect of health system factors
on hypertension management and joint efforts from health system and epidemiological researchers are warranted to
extend knowledge in this area.
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Non-communicable diseases (NCDs)–including cardio-
vascular diseases (CVDs), cancer, diabetes, and chronic re-
spiratory diseases–are the leading causes of global burden
of diseases [1, 2], and are considered as “one of the major
challenges for sustainable development in the 21st cen-
tury” [3]. As one of the most important risk factors of
CVDs, the pandemic of hypertension has become a global
cause for concern [4]. With a prevalence rate of 40 % [1],
it leads to 55 % of the global CVDs mortality burden and
7 % DALYs [5]. Hypertension could be managed well with* Correspondence: fxl@bjmu.edu.cn
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care interventions, even in low resource settings [6, 7].
However, the proportions of hypertensive patients under
appropriate control varies globally, and uncontrolled
hypertension contribute to two-thirds of all strokes and
half of all coronary diseases [8].
Confronted with the world crisis of NCDs, previous
efforts were largely made in building innovative tech-
nologies and improving guidelines in researches and
clinical practices [9, 10]. Only until recently, attentions
have been drawn to the strengthening of a nations’
health system around the principle of universal health
coverage [3]. According to the World Health Organization
(WHO), efforts should be harmonized in strengthening ale is distributed under the terms of the Creative Commons Attribution 4.0
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human resource for health, health information, health
service delivery, and medicines and technologies from a
system perspective in order to provide universal essential
health care [11]. However, paucity of evidence was gener-
ated to answer the “how” question, particularly for the
low-and middle-income countries (LMICs). For example,
a recent systematic review conducted in the year 2013
identified 53 studies that analyzed the effects of health
system strengthening efforts on hypertension awareness,
treatment and control. Among these, only 11 were con-
ducted in LMICs, where only one study was from China.
However, this study did not explore any mechanism of
health system strengthening efforts in improving hyper-
tension management [12].
As the largest developing country, China bears a large
burden of NCDs. Hypertension prevalence doubled in
the past decade and affected around 337 million Chinese
people in the year 2010 [13]. As a silent killer, 80 % of
the CVDs mortality were estimated to be attributed to
hypertension nationally, and more than half of those
were premature death [14]. In this review, we systemat-
ically searched peer-reviewed publications that link
health system level factors with hypertension mana-
gement in the Peoples’ Republic of China. From the
perspective of health system strengthening and popula-
tion health management, we provide the current know-
ledge from China on how to improve a country’s health
system to manage the hypertension epidemic.
Methods
Building on the WHO’s health system monitoring and
evaluation framework, and the six building blocks
framework [15, 16], we developed a conceptual frame-
work that illustrates how health system factors influence
the outcome and impact of hypertension management
(Fig. 1). The framework divides the system level inputs
into six domains, namely health system governance,
physical resources for health, health financing, human
resources for health, health information, and health
service delivery. We refers health system governance to
strategic policy making, system design, effective over-
sight, coalition-building, regulation, and accountability.
We refers physical resources for health to the instru-
ments, equipment and materials to prevent, diagnose,
treat, monitor or remit the diseases. For health finan-
cing, we use a broad concept incorporating the collec-
tion, pooling, and allocation of money to cover the
health needs of the people. Thus both the risk pooling
and purchasing mechanisms are included. As for human
resources for health, we include health workers in dif-
ferent domains of health systems, such as curative, pre-
ventive and rehabilitative care services as well as health
education, promotion and research. And healthinformation is the information technologies, guidelines
which is generated, compiled, analyzed, synthesized and
used by health worker for diagnostic or interventional
support. Service delivery refers to different strategies
and organizational mechanisms to provide quality care.
We incorporate all these concepts referring the use of
health services in this review: access, availability,
utilization, and coverage. We believe that should a coun-
try’s health system be strengthened in these six domains,
it would turn out to deliver adequate and efficient inter-
ventions so as to positively affect the outcomes of hyper-
tension management (i.e. the incidence of hypertensive
disorders, and the awareness, treatment and control for
hypertension), and lead to the mitigation of the burden
of diseases attributed to hypertension (including morbid-
ity, mortality, financial risks, quality of life and financial
burden ushered in by hypertension). Such a framework
was used in this review in developing searching strategy
(Table 1), inclusion and exclusion criteria (Table 2) and
building constructs for data extraction.
Using the strategy listed in Table 1, we systematically
searched the PubMed and China National Knowledge
Infrastructure (CNKI). The data were searched from
inception to April 13, 2016. Two authors independently
screened the search results by title and abstract for
eligible studies. And those potentially eligible articles
were further screened for inclusion by the full texts.
Disagreement were solved by discussions and the inextric-
able ones were further resolved by the last author. To
entrench the data base, references of all the English arti-
cles left for full texts analysis were manually screened.
We developed a data extraction form (Additional file 1:
Appendix 1), and we built the main constructs for data
extraction according to the conceptual framework. Kh
Huang, Yt Song and Yh He conducted data extraction
under the last author’s supervision. The data were struc-
tured by study number, first author, title, published year,
study year, study design, setting, sample characteristics,
health system factors, the outcomes and the impacts of
hypertension management. And quality of the studies
were appraised according to their study designs.
Conceptually, studies investigating the effect of health
system factors on hypertension management were classi-
fied and described according to the framework. We then
described the key findings based on the extracted data.
Results
Five hundred seventy-two publications were identified
from PubMed searches and 19 from CNKI, where 93
articles were screened out by title and abstract according
to the inclusion and exclusion criteria. Full texts of the
93 articles were obtained and assessed for relevance and
ten articles were left according to the inclusion and
exclusion criteria for this review. All references of the 10
Fig. 1 Conceptual framework for health system strengthening and hypertension management
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cation were added.
Among the 83 articles excluded, 29 were epidemio-
logical researches purely described the prevalence, aware-
ness, treatment and control of hypertension in China.
Twenty-three reported the experiences of community
based health promotion programs. These studies were
excluded because mechanisms were not disentangled and
no efforts were made to link to health system factors. And
the other 31 articles were excluded either because the
study setting was not in mainland China, or the study was
not relative to the outcomes of hypertension management,
or the study focused only on mortality, morbidity, quality
of life or financial burden attributed to hypertension, or
the studies did not provide adequate information.
To describe the current landscape of the outcomes of
hypertension management in China, we intentionallyTable 1 Searching strategy
(((((Humans[Mesh]) AND Hypertension[Mesh]) AND China[Tiab]) AND
(Case Reports[Publication Type] OR Observational Study[Publication Type]
OR Randomized Controlled Trial[Publication Type] OR Comparative
Study[Publication Type] OR Evaluation Studies[Publication Type] OR
Meta-Analysis[Publication Type] OR Classical Article [Publication Type] OR
Corrected and Republished Article[Publication Type] OR Support of
Research[Publication Type] OR Health Surveys[Mesh] OR Health Services
Research[Mesh])) AND (Delivery of Health Care, Integrated[Mesh] OR
Delivery of Health Care[Mesh] OR Health Services Accessibility[Mesh] OR
Primary Health Care[Mesh] OR Drug Utilization Review[Mesh] OR Program
Evaluation[Mesh] OR Diagnosis[Mesh] OR Self Care[Mesh] OR Health
Education[Mesh] OR Equipment and Supplies[Mesh] OR Health Facilities
[Mesh] OR Pharmacy[Mesh] OR Pharmaceutical Services[Mesh] OR Health
Manpower[Mesh] OR Attitude of Health Personnel[Mesh] OR Health
Information Systems[Mesh] OR Health Information Management[Mesh] OR
Guideline [Publication Type] OR Healthcare Financing[Mesh] OR Insurance,
Health[Mesh] OR Insurance Coverage[Mesh] OR Fees and Charges[Mesh]
OR Financing, Government[Mesh] OR Costs and Cost Analysis[Mesh]
OR Patient Participation[Mesh] OR Clinical Governance[Mesh] OR
Leadership[Mesh] OR Politics[Mesh] OR Health Services Administration[Mesh]
OR Health Planning[Mesh] OR Community Health Planning[Mesh] OR
Policy[Mesh] OR Health Policy[Mesh] OR Health Priorities[Mesh] OR
Health Care Reform[Mesh] OR Health System[All Field] OR National
Health Programs[Mesh] OR Social Support[Mesh] OR Social
Determinants of Health[Mesh] OR Health Status[Mesh]))extracted information from the 29 epidemiological studies
that described the trends in hypertension prevalence,
awareness, treatment and control. We combined informa-
tion from these 29 studies with relevant information from
the other 11 papers to describe the current situation for
the outcomes of hypertension management in China.
We finally retained a total of 11 researches conducted in
China according to our framework. The study periods
ranged from the year 2010 to 2015 (Fig. 2). We appraised
quality of the researches according to their study designs.
Two of the studies included were randomized control
trials (RCTs), three were based on quasi-experimental
designs, and six were cross-sectional studies. All these
researches were conducted in mainland China, with the
study population varies from 213 to 29,411.Table 2 Inclusion and exclusion criteria
Inclusion criteria
Studies conducted in Chinese population.
Studies that reported the effect of at least one health system factors on
the outcome or impact of hypertension management. Outcomes of
hypertension management refers to hypertension awareness, treatment
and control. Impact of hypertension management refers to
mortality, morbidity, financial risks or quality of life that were
attributed to hypertension.
Studies that reported hypertension prevalence, awareness, treatment
or control.
Studies that reported any of the following the population impact of
hypertension.
Exclusion criteria
Studies not conducted on humankind.
Studies conducted outside China.
All commentaries, letters and editorials.
Studies merely quantify the effects of personal behavioral or modifiable
risk factors on hypertension outcomes.
Studies that only describe the current knowledge of hypertension, i.e
awareness, treatment and control.
Studies that merely focus on the population impact of hypertension like
mortality, morbidity or financial risk.
Studies that only concentrated on community interventions to
improve hypertension management without clearly explications of
the mechanisms.
Fig. 2 Flowchart demonstrating literature review procedure. *CNKI, China National Knowledge Infrastructure
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As reported, 27.2 % of the Chinese adults aged 35 to
74 years, representing 129,824,000 persons, had hyper-
tension in 2000 [17]. Whilst 10 years later, based on na-
tional data, a prevalence of 40.9 % among people aged
45 years or older was reached [13]. The rapid rising in
prevalence seems weird but was corroborated by other
sources [13, 17–22]. For example using the WHO’s
Study on Global Aging and Adult Health (SAGE) data,
Basu et.al. reported a prevalence of 39 % in China during
2007–2010 for people no less than 45 years of age [23].
Whilst with the same data, Lloyd-Sherlock et.al reported
a prevalence rate of 59.5 % for Chinese people aged no
less than 50 years of age [24]. In summary, hypertension
awareness, treatment and control were just 33.7 19.9 and
12.6 % in 1991, but increased to 50.0, 56.1 and 36.4 % in
2012. Although improvement were made in improving its
management during the past decade, the rates were still
unacceptably low, since the screening and routine man-
agement of hypertension has been freely provided in
China’s current health reform since 2009 [22, 24–31]. The
project was included in national essential public health
service to provide the population with health record estab-
lishment and blood pressure monitoring. And as for the
hypertensives screened out, it required the primary health
center to do at least four follow-ups each year [32].
Furthermore, the effective management of hypertensionlargely becomes a case identification problem since only
half of the Chinese people with hypertension are aware of
their disorders, whlist majority of the hypertensive individ-
uals who were aware of their hypertension received anti-
hypertensive medication and most appeared to be under
effective control [13].
Health system factors associated with good hypertension
management
Finally 11 most relevant researches investigating the ef-
fects of health system factors on the outcomes or impact
of hypertension management were retained. All these
identified studies just analyzed the effectiveness of health
system factors on hypertension awareness, treatment
and control. But none of them intended to link health
system factors and incidence of hypertension nor the
morbidity, mortality, quality of life or financial burden.
One was about health system governance investigating
the performance of different organized community health
care centers, three were about health financing comparing
differences in insurance coverage, three were about health
information practicing the hypertension guidelines of
China or the WHO, and the rest four were about mecha-
nisms of health service delivery. Unfortunately it was not
yet studied for the effects of other two health system
domains, namely human resources for health and physical
resources for health on the outcomes or impact of hyper-
tension management in China (Table 3).
Table 3 Key findings of the eleven most important studies
Author Published year No. and title Source Study population Objective Key findings
Health System
Governance
Wong et al 2012 Performance Comparison
among the Major Healthcare
Financing Systems in Six Cities
of the Pearl River Delta Region,
Mainland China.








The hypertension treatment rate in hospital-funded
community health care centers (CHCs) ranged from
83.1 to 92.1 %, which was lower in government-
funded CHCs (70.3 %, adjusted OR 0.46 95 %
CI 0.33–0.66) and private-funded CHCs (29.9 %,
adjusted OR 0.03 95 % CI 0.02–0.05 ); the control
rate in hospital-funded CHCs 22.7 %, ranged
from 20.1 to 28.9 %, which was higher in the
Government-funded (25.8 %, adjusted OR 1.63,
95 % CI 1.16–2.29), lower in the private-funded
CHC (8.9 %, adjusted OR 0.15 95 % CI 0.069–0.31).
Health
Financing
Guo et al 2015 The dynamics of hypertension
prevalence, awareness, treatment,










Compared with those without medical insurance,
hypertensive patients who had medical insurance
were more likely to be aware of their hypertensive
condition (aOR 1.5, 95 % CI 1.4–1.7), more likely to
be medicated for hypertension (aOR 1.7, 95 % CI
1.5–1.8) and more likely to control their blood
pressure within normal range (aOR 1.3, 95 %
CI 1.2–1.4).




treatment, and control in
the WHO SAGE study.
Hypertension 15050 subject in





Compared with people covered by mandatory
insurance, the risk of being undiagnosed was
higher (aOR 4.286, 95 % CI 1.159–15.84, ten times,
95 % CI 2.1–47.4 in Chinese cohort), the risk of
being untreated was near four times higher (aOR
4.64, 95 % CI 1.05–20.46), as well as the risk of
being uncontrolled (aOR 4.51, 95 % CI 0.98–20.82) .
Feng et al 2014 Health system strengthening
and hypertension awareness,
treatment and control:data







Compare the effect of
insurance providing
costs of outpatient
care with those that
contributed nothing
to this part
Those with insurance that covered the costs of
outpatient care were less likely to be unaware of
their hypertension (30.1 % VS 44.4 %, aRR: 0.74;
95 % CI: 0.62–0.88) , to be untreated for it (38.2 %
VS 57.8 %, aRR: 0.80; 95 % CI: 0.68–0.93) and to be
not controlling it effectively (71.0 % VS 81.0 %, aRR:
0.90; 95 % CI: 0.83–1.00), when compared with




Wang et al 2010 Hypertension Control in
Communities (HCC): evaluation










After 1-year intervention, hypertension control
rate raised from 21.6 to 74.7 %(P < 0.05), with an
estimated effect of 53.1 % (95 % CI 52.4–53.8 %).
Li et al 2015 Effects of guideline-based
hypertension management in













After 2 years following up, hypertension treatment
and control increased in both groups and the
control rate increased more significantly in the
guideline-based group (from 31.1 to 37.9 % in the
traditional group, and from 26.9 to 64.3 % in the
guideline-based group, P < 0.001).
Mendis et al 2010 Cardiovascular risk management
and its impact on hypertension
2397 patients in
China and Nigeria
After 12-month following up, the reductions of















Table 3 Key findings of the eleven most important studies (Continued)







of WHO CVD risk
management package
pressure were significantly greater in the
intervention group, with the marginal effects
size of 3.86 and 1.53 mmHg in China (−13.28
vs −9.42 mmHg, −6.07 vs −4.54 mmHg, P < 0.001).
Health Service
delivery
Lu et al 2015 Community-based interventions
in hypertensive patients a












Compared with self-learning, after the 2-y
intervention, the likelihood of normalized
BP was greater in lecture group (from41.2
to 63.2 %, p < 0.001, aOR 2.37, 95 % CI
1.26–4.47) and interactive workshop group
(from 40.2 to 86.3 %, p < 0.001, aOR 14.66,
95 % CI 6.59–32.62 and 2.37).














Systolic blood pressure and diastolic blood
pressure decreased significantly by 10.9 and
4.0 mmHg in the treatment group (P < 0.001).
Niu et al 2014 Differences and determinants
in access to essential public
health services in China a







Evaluate the effect of
accessibility
The control rate in those who lived less
than 5 min away from the nearest health
institution was 39.3 %, slightly higher
than the rate for those who lived more
than 20 min away, which was 35.8 %
(aOR 1.03, 95 % CI 0.60–1.79).




Control in China: A
Modelling Study




Treating all hypertensives for primary
and secondary prevention to goal
of <140/90 if age 35–64 years, goal
of <150/90 if age65 could prevent
about 800,000 cardiovascular disease
events annually (95 % CI 0.6–1.0 million)
and was borderline cost-effective
incremental to treating only cardiovascular
disease and stage two patients (2015
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Only one cross-sectional study explored the effect of
health governance on hypertension management out-
comes. Wong et al conducted the study in six cities of
southern China in the year 2010 [33]. Using data covering
about 1830 hypertensive patients, the study compared
performance of hypertension management among three
different organized community health care centers
(CHCs). The authors found that compared with hospital-
funded CHCs, government-funded CHCs had significantly
lower prescriptions of anti-hypertensive pharmaceutics
with an aOR of 0.46 (95 % CI 0.33–0.66). However hyper-
tension subjects managed by government-funded CHCs
were more likely to control their blood pressure ad-
equately (aOR 1.63, 95 % CI 1.16–2.29), while those in
privately-funded CHCs were less likely to achieve optimal
blood pressure control (aOR 0.15, 95 % CI 0.07–0.31).
The authors interpreted that government-funded pri-
mary care were less incentivized to prescribe anti-
hypertensive agents, and were more willing to implement
policies and guidelines. Since the study was institutional
based which only recruited hypertensive patients for
study, differences in hypertension awareness for popula-
tion managed by these three types of CHCs were not
analyzed.
Health financing
All the three papers were based on cross-sectional
designs and analyzed the effects of health insurance
coverage on the outcomes of hypertension management.
The initial attempt was made by Feng et al. [13] in 2014.
Using national data from the China Health and Retire-
ment Longitudinal Study (CHARLs), which investigated
17,708 Chinese individuals aged 45 or older, they found
that health insurance coverage was the single most
important factor associated with good hypertension
management in China. As the authors reported, when
compared with patients who were members of insurance
schemes that cover costs of outpatient care, such as the
Urban Employee Basic Medical Insurance Scheme and
the Government Insurance Scheme, those who were
members of insurance schemes that do not covered costs
of outpatient care, like the Urban Resident Basic Medical
Insurance Scheme or the New Cooperative Medical
Scheme, had nearly 30 % lower awareness (aRR 0.74, 95 %
CI 0.62–0.88), 20 % lower treatment (aRR 0.80, 95 % CI
0.68–0.93) and 10 % lower control (aRR 0.90, 95 % CI
0.83–1.00) rates for their hypertensive disorders. Data
from other sources strengthened such associations. For
example, using data from the China Health and Nutrition
Surveys (CHNS), Guo et al. reported in the year 2015 that
hypertensive patients who had medical insurance were
more likely to be aware of their hypertensive condition
(aOR 1.50, 95 % CI 1.40–1.70), more likely to bemedicated for hypertension (aOR 1.70, 95 % CI 1.50–1.80)
and more likely to control their blood pressure within
normal range (aOR 1.30, 95 % CI 1.20–1.40) [22]. And
using the SAGE data, Basu et al. found that compared
with people covered by mandatory insurance, those cov-
ered by voluntary insurance had a ten times greater
odds of undiagnosed hypertension (95 % CI 2.10–
47.40) in the Chinese sample, and the risk of being un-
treated was near four times higher (aOR 4.64, 95 % CI
1.05–20.46), as well as the risk of being uncontrolled (aOR
4.51, 95 % CI 0.98–20.82) [23].
Health information
The WHO developed a guideline in the World Health
Report 2002 using a total risk approach for the preven-
tion of cardiovascular disease [34]. Based on regression
models with age, sex, smoking, blood pressure, blood
cholesterol, and presence of diabetes as predictors, indi-
viduals could be classified into four risk categories of
fatal or nonfatal vascular events: very high risk, high
risk, moderate risk and low risk. For the individuals of
very high or high risk, 3–6 months’ following up for risk
monitoring are recommended, 6–12 months’ following
up intervals are suggested for those at moderate risk,
whilst no follow up were suggested for low risk individ-
uals other than health education on life style modifica-
tions. Following up interventions include regular blood
pressure monitoring, lifestyle modification consultation
like dietary changes, physical activity and weight control,
alcohol consumption control, and anti-hypertensive
prescription and adjustment. A cardiovascular risk man-
agement package was further developed by the WHO
later [35]. Main elements includes i) risk-assessment and
risk-management algorithms; lifestyle counseling proto-
cols; anti-hypertensive agents’ treatment protocols; re-
ferral pathways and follow-up schedules; ii) tools for
both providers and patients (training program and man-
ual; self-management tools; personal health records; and
tools for improving adherence).
Following the WHO, China already developed its own
guidelines called Chinese Guidelines for the Management
of Hypertension [36]. The Guideline firstly described the
current situation of the increasing prevalence and rela-
tively ineffective management of hypertension in China.
And it then recommended a combination of primary, sec-
ondary and tertiary prevention, where two strategies were
proposed: population strategy and high risk strategy. The
population strategy emphasized a healthy lifestyle, health
education, community involvement for all citizens; whilst
the high risk strategy recommended health examinations
and health management targeting high risk population. As
for all the hypertensive patients, the Guideline suggested
the establishment of personal health record, and commu-
nity health promotions to improve outpatient attendances
Huang et al. Global Health Research and Policy  (2016) 1:13 Page 8 of 10and self-management. Since the Chinese guideline was de-
veloped based on the WHO’s, they were similar in most
parts. However, none risk assessment algorithms were
presented in the Chinese guideline.
Three included articles assessed the effects in carrying
out such guidelines for hypertension management. A
trial by Wang et al. carried out in six provinces in China
evaluated the effect of guideline-based blood pressure
management [37]. The authors reported that after 1-year
intervention, hypertension control rate raised from 21.6
to 74.7 %( P < 0.05), with an estimated effect of 53.1 %
(95 % CI 52.4–53.8 %). Li et al. did a quasi-experiment
in the year 2015 comparing the performance between
traditional therapy and the guideline-based hypertension
management [38]. The traditional therapy referred to
health education on what is hypertension, the potential
consequence of hypertension and the risk factors associ-
ated with hypertension. After 2 years follow up, the
study showed that hypertension treatment and control
increased in both groups and the control rate increased
more significantly in the guideline-based group (from
31.1 to 37.9 % in the traditional group, and from 26.9 to
64.3 % in the guideline-based group, P < 0.001). Mendis
et al. conducted a clustered randomized control trial
based on WHO cerebrovascular disease risk management
package in China and Nigeria in the year 2006 [7]. The
study indicated that introduction of the package resulted in
a significant increase in the prescribing of anti-hypertensive
agents and after 12-month follow up, the reductions of sys-
tolic blood pressure and diastolic blood pressure were sig-
nificantly greater in the intervention group, with the
marginal effects size of 3.86and 1.53 mmHg in China
(−13.28 vs −9.42 mmHg, −6.07 vs −4.54 mmHg, P < 0.001).
Health service delivery
Four researches explicated various mechanisms on how
to deliver essential health care service to the hyperten-
sive patients properly and efficiently, among which two
randomized control trials investigated strategies to im-
prove the efficacy of lifestyle health education practices;
and the other two cross-sectional studies, one analyzed
the association between access to health care and hyperten-
sion management outcomes. And the other one is a model-
based study evaluating the gains and cost-effectiveness of
implementing total patients management as compare to
severe case management.
Lu et al. conducted a community based health education
trial in Dongguan City, Guangdong province during
2011–2013 [39]. With a small sample size of 347, the
authors compared the performance of three health educa-
tion strategies in improving the outcomes of hypertension
management. It found that regular use of medications to
treat hypertension was more frequent when monthly
interactive education workshop and monthly didacticlecture were used (92.3 and 79.8 % vs 50.9 %, P = 0.001),
as compared to the self-learning material distribution
strategy. And hypertension control rates were also higher
when the two more active health education strategies were
used (aOR 14.66, 95 % CI 6.59–32.62 and 2.37, 95 % CI
1.26–4.47 respectively). The other study conducted by
Yun et al. in Tianjin in 2014 corroborated the positive
effects for such active education strategy [40]. Based on a
“Zhiji management”, i.e. health education by friends, it
found systolic blood pressure and diastolic blood pressure
decreased significantly by 10.9 and 4.0 mmHg in the treat-
ment group (P < 0.001).
Niu et al. assessed the association of accessibility of
essential public health services and good hypertension
management [41]. It was reported that the distance
between the nearest primary health care institution and
the homes of patients could influence the likelihood to
the hypertensives to achieve optimal blood pressure
control, where the control rate in those who lived less
than 5 min away from the nearest health institution was
39.3 %, slightly higher than the rate for those who lived
more than 20 min away, which was 35.8 % (aOR
1.03, 95 % CI 0.60–1.79).
Gu et al. conducted a model-based cost-effectiveness
analysis comparing total patients management with
severe case management. It was found that treating all
hypertensives for primary and secondary prevention to
goal of <140/90 if age 35–64 years, goal of <150/90 if
age ≥65 could prevent about 800,000 cardiovascular
disease events annually (95 % CI 0.6–1.0 million) and
was borderline cost-effective incremental to treating only
cardiovascular disease and stage two patients (2015
Int$13,000 per QALY gained [95 % CI, Int$10,000 to
Int$18,000]) [42]. That means the total patients manage-
ment strategy seems to be more effective with slightly
incremental cost than severe case management.
Conclusions
The prevalence of hypertension has been rising rapidly
in China. Our systematical search found quite a few
epidemiological researches on the prevalence, awareness,
treatment and control of hypertension in China which
had been intentionally described. It was reported that
the management of hypertension in China is a detection
problem rather than treatment problem. And the efforts
of public health community were also abundant, mainly
investing in community based health promotion pro-
grams. However, less attentions were paid by the Chinese
researchers to investigate in the mechanisms that linked
various health system factors to the outcome and impact
of hypertension management in China, while no evidence
was found to clearly link between health system factors
and hypertension incidence or its population impact, such
as morbidity, mortality, quality of life and financial
Huang et al. Global Health Research and Policy  (2016) 1:13 Page 9 of 10burden. For system factors, we identified no evidence on
the association between human resources for health and
physical resources for health and hypertension manage-
ment. While we only identified paucity of evidence with
limited study quality, showing that the improving health
system governance, health finance, health information,
and health service delivery can make a difference on
hypertension management since good governance in com-
munity health centers, more generous health insurance
covering outpatient care, available guideline directing
management and interactive health education strategy as
well as total patients management were reported to be as-
sociated with good hypertension management. It is there-
fore strongly called for joint efforts from health system and
epidemiological researchers to extend knowledge in this
area.
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